fda

Is the FDA Still Approving New Drugs?

Lately the FDA seems more reluctant to approve new drugs than it once was. Some observers believe that Merck’s (NYSE: MRK) 2004 Vioxx recall touched off a new safety-conscious attitude at the FDA, skewing the way the agency viewed a drug’s risk versus its benefit. Others think that the slowdown in approvals simply results from […]